David Entenberg
banner
dentenberg.bsky.social
David Entenberg
@dentenberg.bsky.social
Associate Professor, co-Director of the Gruss-Lipper Biophotonics Center, Einstein College of Medicine
Reposted by David Entenberg
Great @cdi-einstein.bsky.social seminar by Jose Javier Bravo Cordero from @mountsinainyc.bsky.social covering ECM architecture, metabolism and neuroscience. Fantastic work! Thanks for visiting us!
October 2, 2025 at 4:55 PM
Reposted by David Entenberg
Metastasis drives most #breastcancer deaths.
A new study led by Dr. Rachel Hazan of Einstein shows how the Wnt/ERK/CDK4/6 pathway fuels the growth of aggressive hybrid tumor cells. Blocking it slowed tumor growth and reduced aggressiveness.
In British J of Cancer tinyurl.com/5xpscst6
#metasasis
September 3, 2025 at 4:25 PM
Please join me in congratulating the newly minted Dr. Madeline Friedman DeLuca! She did a phenomenal job in her thesis defense today!

#ProudPI

@cdi-einstein.bsky.social @einsteinmededu.bsky.social @monteeinsteinpath.bsky.social
August 5, 2025 at 12:37 AM
Was a really great talk!
Really excited to hear the presentation by Dr. Morad on microbiota, dormancy and brain metastasis @gmorad.bsky.social @cdi-einstein.bsky.social - Thanks for sharing your data with us!
March 26, 2025 at 12:53 AM
Congratulations Neta! !מזל טוב
1/8 The Metastasis Research Society’s mission is to support progressive research on processes fundamental to metastasis and connect researchers, clinicians, industry, advocates and patients. Learn more about the vision and research of our next President @netaerez.bsky.social 🧵👇
March 26, 2025 at 12:48 AM
Got to hear the amazing Miriam Merad talk today. Fantastic work she's doing understanding how to better target tumor associated macrophages!
March 20, 2025 at 12:55 AM
What a fantastic day of science! Those were amazing projects!
March 15, 2025 at 5:12 PM
Super excited to hear all the great student research at #WESEF (the second largest science fair in the country).

My list, just 7 of the nearly 800 projects being presented today, shows how students are helping to fight sickle cell disease, lung cancer, and inflammatory bowel disease.
March 15, 2025 at 1:09 PM
Just finished reviewing grants for study section. Quick question for other reviewers. What do you read first when reviewing a grant? Coment on your favorite method and why.

1️⃣ Abstract/Narrative
2️⃣️ Specific Aims
3️⃣ Research Strategy
4️⃣ Biosketches
5️⃣ Straight through like a book

📊 Show results
February 17, 2025 at 5:57 PM
So excited to share the latest work from the amazing Serena Lucotti and the rest of the David Lyden Lab out now in Cell.

Super honored to have been able to help out in this great work!

news.weill.cornell.edu/news/2025/02...

www.cell.com/cell/abstrac...
February 14, 2025 at 2:18 AM
Please write to your representatives in congress asking them to oppose the cuts in NIH funding. Whether you think that limiting overhead is good or bad, drastically cutting funding in such a short time span is destructive. If this stands, the negative impact on science will be felt for generations.
February 11, 2025 at 3:25 AM
Reposted by David Entenberg
Super excited to share the latest work by the amazing Madeline DeLuca-Friedman, now out as a preprint on @BioRxiv!

What's it all about? Keep reading!

www.biorxiv.org/content/10.1...

@cdi-einstein.bsky.social
@einsteinmededu.bsky.social
@monteeinsteinpath.bsky.social
Paclitaxel causes de novo induction of invasive breast cancer cells by repolarizing tumor-associated macrophages
Background Metastasis is the leading cause of breast cancer (BC) death, and tumor cells must migrate and invade to metastasize. BC cells that express the pro-metastatic actin regulatory protein MenaIN...
www.biorxiv.org
February 1, 2025 at 5:22 PM
Ready to help lead breast cancer mestastasis research? Come join our translational team. Role is majority research, but with significant lab management as well. The Researcher & Lab Manager is a person who will be integral to our leadership team!

www.linkedin.com/jobs/view/37...
November 6, 2023 at 10:02 PM